{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:40:31Z","timestamp":1707525631381},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,17]]},"DOI":"10.7759\/cureus.52456","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T23:35:09Z","timestamp":1705534509000},"source":"Crossref","is-referenced-by-count":0,"title":["Anesthetic Management of a Patient With Central Core Disease Undergoing Thoracoscopic Lung Resection: The Importance of Neuromuscular Monitoring at the Masseter Muscle"],"prefix":"10.7759","author":[{"given":"Hiroko","family":"Baba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ichiyanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobukazu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3181b5ae2d","article-title":"Core myopathies and risk of malignant hyperthermia","volume":"109","author":"Klingler W","year":"2009","unstructured":"Klingler W, Rueffert H, Lehmann-Horn F, Girard T, Hopkins PM. Core myopathies and risk of malignant hyperthermia. Anesth Analg. 2009, 109:1167-73. 10.1213\/ANE.0b013e3181b5ae2d","journal-title":"Anesth Analg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/pan.12175","article-title":"Core myopathies and malignant hyperthermia susceptibility: a review","volume":"23","author":"Brislin RP","year":"2013","unstructured":"Brislin RP, Theroux MC. Core myopathies and malignant hyperthermia susceptibility: a review. Paediatr Anaesth. 2013, 23:834-41. 10.1111\/pan.12175","journal-title":"Paediatr Anaesth"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/adc.88.12.1051","article-title":"Central core disease: clinical, pathological, and genetic features","volume":"88","author":"Quinlivan RM","year":"2003","unstructured":"Quinlivan RM, Muller CR, Davis M, et al.. Central core disease: clinical, pathological, and genetic features. Arch Dis Child. 2003, 88:1051-5. 10.1136\/adc.88.12.1051","journal-title":"Arch Dis Child"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm096","article-title":"Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies","volume":"130","author":"Zhou H","year":"2007","unstructured":"Zhou H, Jungbluth H, Sewry CA, et al.. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain. 2007, 130:2024-36. 10.1093\/brain\/awm096","journal-title":"Brain"},{"key":"ref5","unstructured":"Anaesthesia recommendations for central core disease. (2019). Accessed. December 25, 2023: https:\/\/www.orphananesthesia.eu\/en\/rare-diseases\/published-guidelines\/central-core-disease\/813-central-core-disease-4...."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeg262","article-title":"Anaesthetic management of coronary artery bypass grafting in a patient with central core disease and susceptibility to malignant hyperthermia on statin therapy","volume":"91","author":"Johi RR","year":"2003","unstructured":"Johi RR, Mills R, Halsall PJ, Hopkins PM. Anaesthetic management of coronary artery bypass grafting in a patient with central core disease and susceptibility to malignant hyperthermia on statin therapy. Br J Anaesth. 2003, 91:744-7. 10.1093\/bja\/aeg262","journal-title":"Br J Anaesth"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen046","article-title":"Emergency anaesthesia in central core disease","volume":"100","author":"Georgiou AP","year":"2008","unstructured":"Georgiou AP, Gatward J. Emergency anaesthesia in central core disease. Br J Anaesth. 2008, 100:567. 10.1093\/bja\/aen046","journal-title":"Br J Anaesth"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/anae.13738","article-title":"Conceptual and technical insights into the basis of neuromuscular monitoring","volume":"72 Suppl 1","author":"Naguib M","year":"2017","unstructured":"Naguib M, Brull SJ, Johnson KB. Conceptual and technical insights into the basis of neuromuscular monitoring. Anaesthesia. 2017, 72 Suppl 1:16-37. 10.1111\/anae.13738","journal-title":"Anaesthesia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia: pharmacology of triggering","volume":"107","author":"Hopkins PM","year":"2011","unstructured":"Hopkins PM. Malignant hyperthermia: pharmacology of triggering. Br J Anaesth. 2011, 107:48-56. 10.1093\/bja\/aer132","journal-title":"Br J Anaesth"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.09.029","article-title":"Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group","volume":"126","author":"R\u00fcffert H","year":"2021","unstructured":"R\u00fcffert H, Bastian B, Bendixen D, et al.. Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group. Br J Anaesth. 2021, 126:120-30. 10.1016\/j.bja.2020.09.029","journal-title":"Br J Anaesth"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.818456","article-title":"Non-intubated thoracoscopic surgery-tips and tricks from anesthesiological aspects: a mini review","volume":"8","author":"Fabo C","year":"2021","unstructured":"Fabo C, Oszlanyi A, Lantos J, et al.. Non-intubated thoracoscopic surgery-tips and tricks from anesthesiological aspects: a mini review. Front Surg. 2021, 8:818456. 10.3389\/fsurg.2021.818456","journal-title":"Front Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aex318","article-title":"Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation","volume":"119","author":"Hunter JM","year":"2017","unstructured":"Hunter JM. Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation. Br J Anaesth. 2017, 119:i53-62. 10.1093\/bja\/aex318","journal-title":"Br J Anaesth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000004379","article-title":"2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: a report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade","volume":"138","author":"Thilen SR","year":"2023","unstructured":"Thilen SR, Weigel WA, Todd MM, et al.. 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: a report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology. 2023, 138:13-41. 10.1097\/ALN.0000000000004379","journal-title":"Anesthesiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/68.3.239","article-title":"Differential effects of vecuronium on diaphragm and geniohyoid muscle in anaesthetized dogs","volume":"68","author":"Isono S","year":"1992","unstructured":"Isono S, Kochi T, Ide T, Sugimori K, Mizuguchi T, Nishino T. Differential effects of vecuronium on diaphragm and geniohyoid muscle in anaesthetized dogs. Br J Anaesth. 1992, 68:239-43. 10.1093\/bja\/68.3.239","journal-title":"Br J Anaesth"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/aas.12703","article-title":"Rocuronium pharmacokinetics and pharmacodynamics in the adductor pollicis and masseter muscles","volume":"60","author":"Vega EA","year":"2016","unstructured":"Vega EA, Ibacache ME, Anderson BJ, et al.. Rocuronium pharmacokinetics and pharmacodynamics in the adductor pollicis and masseter muscles. Acta Anaesthesiol Scand. 2016, 60:734-46. 10.1111\/aas.12703","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10877-019-00287-y","article-title":"Philips Intellivue NMT module: precision and performance improvements to meet the clinical requirements of neuromuscular block management","volume":"34","author":"Dubois V","year":"2020","unstructured":"Dubois V, Fostier G, Dutrieux M, et al.. Philips Intellivue NMT module: precision and performance improvements to meet the clinical requirements of neuromuscular block management. J Clin Monit Comput. 2020, 34:111-6. 10.1007\/s10877-019-00287-y","journal-title":"J Clin Monit Comput"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/219963-anesthetic-management-of-a-patient-with-central-core-disease-undergoing-thoracoscopic-lung-resection-the-importance-of-neuromuscular-monitoring-at-the-masseter-muscle","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:14Z","timestamp":1707509534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/219963-anesthetic-management-of-a-patient-with-central-core-disease-undergoing-thoracoscopic-lung-resection-the-importance-of-neuromuscular-monitoring-at-the-masseter-muscle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.52456","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,17]]}}}